Search research articles
Contact Us
Filters
Showing results (261-270 of 337) with videos related to
Page
of 34
Sort By:
Science Advances
|
April 22, 2026
Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity
Sergey A Shein, Anna A Korchagina, Li-Ju Wang, et al.
The Journal of Infectious Diseases
|
May 20, 2011
B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation
Zheng Zhang, Xiangsheng Xu, Jiyun Lu, et al.
Gastroenterology
|
October 28, 2008
T cell-derived lymphotoxin regulates liver regeneration
Alexei V Tumanov, Ekaterina P Koroleva, Peter A Christiansen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2023
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
Yuankun Zhang, Qingxiao Song, Kaniel Cassady, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2021
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade
Casey Moore, Ching-Cheng Hsu, Wei-Min Chen, et al.
Oncoimmunology
|
June 7, 2024
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
Soumya Tumbath, Lingxiang Jiang, Xiaoguang Li, et al.
Nature Microbiology
|
April 19, 2017
Bap180/Baf180 is required to maintain homeostasis of intestinal innate immune response in Drosophila and mice
Xiaomeng He, Junjing Yu, Min Wang, et al.
Nature Communications
|
April 3, 2020
Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8<sup>+</sup> T-cell response and effective tumor control
Zhichen Sun, Zhenhua Ren, Kaiting Yang, et al.
Gastroenterology
|
April 27, 2013
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis
Liping Su, Sam C Nalle, Le Shen, et al.
Science Immunology
|
August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
Zhida Liu, Chuanhui Han, Chunbo Dong, et al.
Page
of 34
Search research articles
Search
Showing results (261-270 of 337) with videos related to
Sort By:
Page
of 34
Science Advances
|
April 22, 2026
Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity
Sergey A Shein, Anna A Korchagina, Li-Ju Wang, et al.
The Journal of Infectious Diseases
|
May 20, 2011
B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation
Zheng Zhang, Xiangsheng Xu, Jiyun Lu, et al.
Gastroenterology
|
October 28, 2008
T cell-derived lymphotoxin regulates liver regeneration
Alexei V Tumanov, Ekaterina P Koroleva, Peter A Christiansen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2023
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
Yuankun Zhang, Qingxiao Song, Kaniel Cassady, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2021
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade
Casey Moore, Ching-Cheng Hsu, Wei-Min Chen, et al.
Oncoimmunology
|
June 7, 2024
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
Soumya Tumbath, Lingxiang Jiang, Xiaoguang Li, et al.
Nature Microbiology
|
April 19, 2017
Bap180/Baf180 is required to maintain homeostasis of intestinal innate immune response in Drosophila and mice
Xiaomeng He, Junjing Yu, Min Wang, et al.
Nature Communications
|
April 3, 2020
Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8<sup>+</sup> T-cell response and effective tumor control
Zhichen Sun, Zhenhua Ren, Kaiting Yang, et al.
Gastroenterology
|
April 27, 2013
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis
Liping Su, Sam C Nalle, Le Shen, et al.
Science Immunology
|
August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
Zhida Liu, Chuanhui Han, Chunbo Dong, et al.
Page
of 34